Meet the LIP Research Team
Meet the Research Team from the Lithium Inflammation Psychiatry (LIP) Study at the Karolinska Institute in Stockholm, Sweden.
Low-Dose Lithium Research Team from the Karolinska Institute
Research Team
- Dr. Sudhir Gadh MD is a psychiatrist, Karolinska Institute scientist, US Navy Commander, and founder of Third Element LLC.
- Dr. Lena Backlund MD, PhD has 40 years experience as a clinical psychiatrist, whereof the last 25 years at the Unit for Affective Disorders at Karolinska University Hospital in Huddinge, Stockholm.
- Dr. Peder Bjorling is a Consultant psychiatrist and Psychotherapist specialized in personality disorders since 15 years.
- Dr. Karin Beckman, MD has fourteen years of experience as a clinical psychiatrist, whereof the last seven years in an outpatient unit specialising in bipolar disorder.
Meet the Research Team
- Pilot Study (PDF)
- Funding Appeal
- Meet the Researchers
- News and Announcements
- Mental Health Biomarkers
- Suicide Prevention
- Lithium for Alzheimer’s
- Lithium for Addiction
Linkedin
Map-marked-alt
Youtube
Steam
Low-Dose Lithium in Personality Disorder Team from the Karolinska Institute
Dr. Sudhir Gadh is a board-certified psychiatrist, Commander in the U.S. Navy Medical Corps, and the principal investigator of the LIP Study on lithium and inflammation at the Karolinska Institute in Sweden—home of the Nobel Assembly. Dr. Gadh offers progressive psychiatric care that combines medication and therapy to help patients identify the core issues contributing to their mental health conditions. Dr. Gadh is the lead researcher on an international team from the Karolinska Institute (Sweden) with deep expertise in psychopharmacology and biological psychiatry. The Karolinska Institute team, based at one of the world’s leading psychiatric research centers, has pioneered studies on inflammation in psychiatry, including proteomic profiling of patients with first-episode psychosis and clinical trials of immune-modulating treatments, which aim to inform the biomarker and immunological analyses. The Karolinska team’s track record includes successful conduct of placebo-controlled trials in vulnerable psychiatric populations, high-impact publications on inflammation and mental health, and decades of collective experience in lithium research. Additionally, the partnership with the Karolinska’s proteomics core facility guarantees state-of-the-art measurement of inflammatory markers with rigorous quality control. In summary, the team’s strong scientific background and institutional support provide confidence in the feasibility and integrity of the proposed study.
Martin Schalling, MD, PhD is a professor at the Department of Molecular Medicine and Surgery and the Center for Molecular Medicine at Karolinska Institutet Professor at the Department of Molecular Medicine and Surgery and the Center for Molecular Medicine at Karolinska Institutet and Karolinska University Hospital. He has an MD and a PhD degree from Karolinska Institutet. He was an EMBO postdoctoral fellow and a Fulbright Scholar at Massachusetts Institute of Technology. The aim of Martin´s research is to identify genetic factors that predispose to the development of neuropsychiatric and metabolic disorders. Martin has been responsible for 10 clinical trials, supervised 35 PhD students and has authored over 350 scientific papers. His papers have been cited over 50 000 times and his H index is over 100. Martin has a strong track record as a leader in organizations outside academia. He has written over 20 public debate articles relating to society, healthcare and science. He is chairman of the board of Suicide Zero, board member of Swedish Mental Health Fund and a large health care provider in Sweden (SLSO). He founded the startup company Care to Translate.
Lena Backlund, MD, PhD has 40 years of experience as a clinical psychiatrist, with the last 25 years spent at the Unit for Affective Disorders at Karolinska University Hospital in Huddinge, Stockholm. Her dissertation in 2010 focused on the use of lithium in the treatment of bipolar disorder. In parallel with her clinical work, she is a member of Professor Martin Shalling’s research group at the Department of Molecular Medicine and Surgery and the Center for Molecular Medicine at Karolinska Institutet in Stockholm. She has authored more than 40 scientific papers. She is one of the four founders of the Swedish Association for Bipolar Disorders, aiming at educating and updating physicians’ knowledge of bipolar disorders and their treatment, with emphasis on the use of lithium. She is still an active researcher and supervises four doctoral students.
Dr. Peder Bjorling is a Consultant psychiatrist and Psychotherapist, specialized in personality disorders for 15 years. Medical Director of the Outpatient Clinic for Personality Disorders at Psykiatri Sydvast, Stockholm. Member of the Stockholm Region expert group on Personality Disorders. Previous board member of Suicide Zero. Founder of the Swedish resident psychiatrists’ organisation STP. Author of a popular science book on narcissism and columnist on mental health in the daily newspaper Svenska Dagbladet.
Dr. Karin Beckman, MD, PhD. has fourteen years of experience as a clinical psychiatrist, whereof the last seven years in an outpatient unit specialising in bipolar disorder. Her dissertation in 2018 at the Department of Clinical Neuroscience, Karolinska Institutet, focused on suicide and self-harm in youth, and included epidemiological studies on the subject, as well as one clinical study. She has participated in a total of nine scientific papers. Apart from her clinical work, she works as a teacher at the Karolinska Institutet.